Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185(HER2/neu) monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

Mark D. Pegram, Allen Lipton, Daniel F. Hayes, Barbara L. Weber, Jose M. Baselga, Debu Tripathy, Debbie Baly, Sharon A. Baughman, Tom Twaddell, John A. Glaspy, Dennis J. Slamon

Research output: Contribution to journal › Article › peer-review

1008 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185(HER2/neu) monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences